Latest Period
Q2 2026
Security Snapshot
Strata Critical Medical, Inc. - Common Stock (SRTA) Institutional Ownership
CUSIP: 092667104
13F Institutional Holders and Ownership History from Q1 2019 to Q2 2026
Institutions Reporting
81
Shares (Excl. Options)
20,266,216
Price
$5.27
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- SRTA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 20,266,216
- Total 13F value
- $106,775,734
- Portfolio coverage rank
- 0%
- Share change
- +881,108
- Value change
- +$4,828,503
- Number of holders
- 81
- Shares outstanding
- 86,419,462
- SEC-reported price per share
- $5.27
- Insider filing price
- $5.27
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SRTA - Strata Critical Medical, Inc. - Common Stock is tracked under CUSIP 092667104.
- 81 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 125 to 81 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $233,248,473 to $106,775,734.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 81 institutions filings for Q2 2026.
Security key
092667104
Latest holder period
Q2 2026
13F holders
81
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
SRTA full holder history
Strata Critical Medical, Inc. SEC filings
Strata Critical Medical, Inc. company facts
Strata Critical Medical, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 092667104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
SRTA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Third Point LLC | 5.8% | -5% | $25,300,000 | 5,000,000 | 0% | Third Point LLC | 30 Sep 2025 | |
| Northern Right Capital Management, L.P. | 5.1% | $28,456,580 | 4,398,235 | Northern Right Capital Management, L.P. | 11 Jun 2026 | |||
| BlackRock, Inc. | 5.1% | +2.8% | $21,091,147 | +$760,084 | 4,384,945 | +3.7% | BlackRock, Inc. | 31 Dec 2025 |
| ARK Investment Management LLC | 3.2% | -60% | $14,398,979 | -$24,910,497 | 2,730,855 | -63% | ARK Investment Management LLC | 30 Jun 2026 |
As of 30 Jun 2026, 81 institutional investors reported holding 20,266,216 shares of Strata Critical Medical, Inc. - Common Stock (SRTA). This represents 23% of the company’s total 86,419,462 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
52%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Third Point LLC | 5.8% | 5,000,000 | 0% | 0.57% | $26,350,000 |
| Northern Right Capital Management, L.P. | 5.7% | 4,890,584 | +20% | 7.6% | $25,773,378 |
| BlackRock, Inc. | 5.6% | 4,835,516 | +5.9% | 0% | $25,483,170 |
| ROYCE & ASSOCIATES LP | 3.6% | 3,132,933 | +11% | 0.13% | $16,510,557 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.3% | 2,885,319 | +0.45% | 0% | $15,205,631 |
| AWM Investment Company, Inc. | 3.3% | 2,821,468 | 0% | 1.3% | $14,869,136 |
| ARK Investment Management LLC | 3.2% | 2,730,855 | -63% | 0.09% | $14,391,606 |
| First Eagle Investment Management, LLC | 2.7% | 2,314,614 | +2.1% | 0.02% | $12,198,016 |
| Pillsbury Lake Capital LLC | 2.5% | 2,171,006 | -17% | 3.1% | $11,441,202 |
| GEODE CAPITAL MANAGEMENT, LLC | 2% | 1,755,383 | +3.3% | 0% | $9,253,122 |
| DIMENSIONAL FUND ADVISORS LP | 2% | 1,738,623 | +7.5% | 0% | $9,161,908 |
| STATE STREET CORP | 1.8% | 1,524,390 | +13% | 0% | $8,033,535 |
| Uniplan Investment Counsel, Inc. | 1.7% | 1,429,514 | +9.9% | 0.71% | $7,533,542 |
| Bank of New York Mellon Corp | 1.3% | 1,141,035 | +5.7% | 0% | $6,013,255 |
| Sumitomo Mitsui Trust Group, Inc. | 1.2% | 1,052,611 | -36% | 0% | $5,547,260 |
| Amova Asset Management Americas, Inc. | 1.1% | 989,100 | -40% | 0.07% | $5,202,666 |
| NORTHERN TRUST CORP | 0.78% | 676,575 | +5.1% | 0% | $3,565,551 |
| Creek Drive Management Group LLC | 0.68% | 586,200 | -45% | 1.9% | $3,089,274 |
| CITIGROUP INC | 0.61% | 526,859 | +445% | 0% | $2,776,547 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.61% | 526,143 | +8.8% | 0% | $2,772,774 |
| Qube Research & Technologies Ltd | 0.61% | 524,627 | 0% | $2,764,784 | |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.58% | 503,872 | -6.6% | 0.19% | $2,655,405 |
| Granahan Investment Management, LLC | 0.58% | 503,005 | 0.09% | $2,650,836 | |
| Cerity Partners LLC | 0.58% | 502,238 | +100% | 0% | $2,646,794 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 492,386 | +3.7% | 0% | $2,594,874 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
30
Latest
Q2 2026
Rows shown
1-25 of 30
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 20,266,216 | $106,775,734 | +$4,828,503 | $5.27 | 81 |
| 2026 Q1 | 55,803,500 | $233,248,473 | +$14,870,374 | $4.18 | 125 |
| 2025 Q4 | 52,008,878 | $250,146,841 | +$9,910,903 | $4.81 | 126 |
| 2025 Q3 | 47,286,362 | $239,206,127 | +$14,930,619 | $5.06 | 136 |
| 2025 Q2 | 44,455,005 | $179,183,574 | +$8,630,071 | $4.03 | 124 |
| 2025 Q1 | 42,573,092 | $116,252,652 | -$2,666,480 | $2.73 | 117 |
| 2024 Q4 | 43,353,242 | $184,230,440 | +$11,523,087 | $4.25 | 119 |
| 2024 Q3 | 41,177,565 | $121,252,962 | +$5,683,512 | $2.94 | 119 |
| 2024 Q2 | 38,807,858 | $134,994,588 | +$4,500,006 | $3.48 | 115 |
| 2024 Q1 | 37,468,293 | $106,750,264 | +$6,028,180 | $2.85 | 112 |
| 2023 Q4 | 35,332,178 | $124,791,578 | +$3,955,619 | $3.53 | 98 |
| 2023 Q3 | 34,343,140 | $88,930,371 | -$7,931,136 | $2.59 | 101 |
| 2023 Q2 | 36,346,707 | $143,117,927 | -$1,612,269 | $3.94 | 91 |
| 2023 Q1 | 37,275,583 | $125,607,577 | -$6,294,513 | $3.38 | 88 |
| 2022 Q4 | 39,093,511 | $139,905,215 | +$648,352 | $3.58 | 91 |
| 2022 Q3 | 38,748,710 | $156,009,485 | -$2,349,790 | $4.03 | 90 |
| 2022 Q2 | 39,320,621 | $193,883,296 | +$22,393,418 | $4.46 | 86 |
| 2022 Q1 | 32,701,085 | $275,248,499 | -$27,554,097 | $8.49 | 70 |
| 2021 Q4 | 35,699,144 | $315,671,183 | +$72,718,787 | $8.83 | 77 |
| 2021 Q3 | 27,281,482 | $284,480,728 | +$37,270,022 | $10.40 | 77 |
| 2021 Q2 | 23,713,890 | $249,189,810 | +$249,182,810 | $10.50 | 74 |
| 2021 Q1 | 700 | $7,000 | $10.14 | 1 | |
| 2020 Q4 | 700 | $7,000 | $10.00 | 1 | |
| 2020 Q3 | 700 | $7,000 | $10.00 | 1 | |
| 2020 Q2 | 700 | $7,000 | $10.00 | 1 |